Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta blockers in heart failure

F Waagstein1

  • 1Wallenberg Laboratory, Sahlgren's Hospital, Göteborg, Sweden.

Cardiology
|January 1, 1993
PubMed
Summary

Beta-blocking drugs show potential in treating chronic heart failure by improving symptoms and hemodynamics. Further research is ongoing to confirm their benefits, especially regarding survival rates in heart failure patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.

Clinical pharmacology and therapeutics·2013
Same author

Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.

Clinical pharmacology and therapeutics·2012
Same author

Effects of complete heart block on myocardial function, morphology, and energy metabolism in the rat.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2007
Same author

In vivo MR imaging of magnetically labeled human embryonic stem cells.

Life sciences·2006
Same author

Invited for debate: is there a virus-specific matrix destruction in the course of disease in dilated cardiomyopathy?

Ernst Schering Research Foundation workshop·2005
Same author

Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.

European journal of heart failure·2003

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • The use of beta-blocking drugs for chronic heart failure is debated due to potential negative inotropic effects.
  • Uncontrolled studies suggest benefits in mild to moderate heart failure, improving symptoms and hemodynamics.

Purpose of the Study:

  • To explore the efficacy of beta-blocking drugs in chronic heart failure.
  • To investigate the mechanism of improved cardiac function through beta-receptor upregulation.

Main Methods:

  • Review of uncontrolled studies in patients with dilated cardiomyopathy.
  • Titration of beta-blocking drugs from low-dose starting points.

Main Results:

  • Improvement in surrogate endpoints like symptoms and hemodynamic parameters observed in some studies.
  • Presumed mechanism involves upregulation of myocardial beta-receptors.

Conclusions:

  • Beta-blocking drugs may improve the clinical state in certain heart failure patients.
  • Conflicting data exists on exercise tolerance; survival data is lacking.
  • Prospective randomized trials are underway to further evaluate beta-blocker potential in heart failure.

Related Experiment Videos